[go: up one dir, main page]

WO2012040579A3 - Criblage moléculaire à travers des matrices de rigidité définie - Google Patents

Criblage moléculaire à travers des matrices de rigidité définie Download PDF

Info

Publication number
WO2012040579A3
WO2012040579A3 PCT/US2011/052990 US2011052990W WO2012040579A3 WO 2012040579 A3 WO2012040579 A3 WO 2012040579A3 US 2011052990 W US2011052990 W US 2011052990W WO 2012040579 A3 WO2012040579 A3 WO 2012040579A3
Authority
WO
WIPO (PCT)
Prior art keywords
molecular screening
defined stiffness
stiffness matrices
methods
matrices
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2011/052990
Other languages
English (en)
Other versions
WO2012040579A2 (fr
Inventor
Daniel Tschumperlin
Justin Mih
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard University
Original Assignee
Harvard University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard University filed Critical Harvard University
Publication of WO2012040579A2 publication Critical patent/WO2012040579A2/fr
Publication of WO2012040579A3 publication Critical patent/WO2012040579A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des procédés de criblage basés sur des cellules qui recourent à des substrats d'une rigidité définie par l'utilisateur. Lesdits procédés peuvent être utilisés pour évaluer l'importance et la nature des réponses cellulaires à un médicament dans une gamme de rigidité physiologique.
PCT/US2011/052990 2010-09-23 2011-09-23 Criblage moléculaire à travers des matrices de rigidité définie Ceased WO2012040579A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38594210P 2010-09-23 2010-09-23
US61/385,942 2010-09-23

Publications (2)

Publication Number Publication Date
WO2012040579A2 WO2012040579A2 (fr) 2012-03-29
WO2012040579A3 true WO2012040579A3 (fr) 2012-06-28

Family

ID=45874402

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/052990 Ceased WO2012040579A2 (fr) 2010-09-23 2011-09-23 Criblage moléculaire à travers des matrices de rigidité définie

Country Status (1)

Country Link
WO (1) WO2012040579A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2438391B1 (es) * 2012-06-12 2014-10-22 Universidad De Zaragoza Dispositivo de cultivo celular y método asociado a dicho dispositivo
WO2015020614A1 (fr) * 2013-08-07 2015-02-12 Agency For Science, Technology And Research Procédés, appareils et systèmes de culture de cellules et de tissus

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
KOSTIC, A. ET AL.: "Differential matrix rigidity response in breast cancer cell lines corelates with the tissue tropism", PLOS ONE., vol. 4, no. 7, 23 July 2009 (2009-07-23), pages E6361 *
LAU, K. C. ET AL.: "Automated imaging of circulating fluorocytes for the diagnosis of erythropoietic protoporphyria: A pilot study for population screening", JOURNAL OF MEDICAL SCREENING., vol. 15, no. 4, 2008, pages 199 - 203 *
MCDANIEL, D. P. ET AL.: "The stiffness of collagen fibrils influences vascular smooth muscle cell phenotype", BIOPHYSICAL JOURNAL., vol. 92, no. 5, 8 December 2006 (2006-12-08), pages 1759 - 1769 *
REHFELDT, F. ET AL.: "Cell responses to the mechanochemical microenvironment - Implications for regenerative medicine and drug delivery", ADVANCED DRUG DELIVERY REVIEWS., vol. 59, 14 August 2007 (2007-08-14), pages 1329 - 1339, XP022343631, DOI: doi:10.1016/j.addr.2007.08.007 *
SEMLER, E. J.: "Engineering hepatocellular morphogenesis and function via ligand-presenting hydrogels with graded mechanical compliance", BIOTECHNOLOGY AND BIOENGINEERING., vol. 89, no. 3, 22 December 2004 (2004-12-22), pages 296 - 307 *

Also Published As

Publication number Publication date
WO2012040579A2 (fr) 2012-03-29

Similar Documents

Publication Publication Date Title
EP2922841B8 (fr) Composés pyridyle substitués par alkyl-amide, utiles comme modulateurs d'il-12, il-23 et/ou de réponses à l'ifn alpha
MX2009004883A (es) Piridil sulfoximinas multi-substituidas y su uso como insecticidas.
WO2012088029A3 (fr) Attestation d'application sécurisée à l'aide de noyaux de mesure dynamique
GB2473987B (en) Organic thin film transistor, method of manufacturing the same and display device using the same
WO2009100102A3 (fr) Variants ts23 de l’alpha-amylase à propriétés modifiées
EP2654416A4 (fr) Appareil et procédé pour éliminer les infestations d'arthropodes
BRPI0921822A2 (pt) composição compreendendo polímero e enzima
WO2011133504A3 (fr) Nanozymes, procédés de production de nanozymes, et procédés d'utilisation de nanozymes
GB2467711B (en) Organic thin film transistors, active matrix organic optical devices and methods of making the same
WO2011097514A3 (fr) Modèles dotés de repères d'alignement à contraste élevé
WO2010148374A3 (fr) Réseaux organométalliques et leurs procédés de fabrication
WO2008008857A3 (fr) Macromolécules thiolées et procédés de fabrication et d'utilisation de celles-ci
BRPI0914809A2 (pt) aparelho de display e método de fabricação do mesmo, e substrato de matriz ativa
EP2527675A4 (fr) Dispositif de palier à pression statique et platine munie de celui-ci
WO2013033456A3 (fr) Nanofils microbiens et procédés de fabrication et d'utilisation
GB2467259B (en) Organic thin film transistors, active matrix organic optical devices and methods of making the same
GB0814305D0 (en) Organic thin film transistors and methods of making the same
EP3088951A4 (fr) Substrat de réseau, son procédé de préparation, carte mère comprenant un substrat de réseau et appareil d'affichage
WO2006116622A3 (fr) Nouveaux procedes et dispositifs d'evaluation de substances toxiques
EP2963071A4 (fr) Nouveau polymère greffé, substrat sensible à la température pour culture cellulaire l'utilisant et procédé de production correspondant, support de chromatographie en phase liquide présentant le nouveau polymère greffé sous forme immobilisée et procédé de chromatographie en phase liquide l'utilisant
WO2008127711A3 (fr) Interférons d'origine rhésus et cynomolgus et leurs utilisations
EP2452445A4 (fr) Formation de faisceau à l'aide de livres de codes de base et différentiel
WO2012040579A3 (fr) Criblage moléculaire à travers des matrices de rigidité définie
EA201300260A1 (ru) Микрочипы с малыми молекулами и способы их изготовления и применения
FR2962396B1 (fr) Equipement mobile pour le tansfert et le deplacement notamment de meubles

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11827612

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11827612

Country of ref document: EP

Kind code of ref document: A2